Categories: News

Bybit x FXStreet TradFi Report: Why This Week’s CPI and PPI Data Is a Make-or-Break Event

DUBAI, UAE, Sept. 10, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has released a new Bybit x FXStreet TradFi, highlighting why this week’s U.S. inflation data could be a pivotal moment for global markets.

- Advertisement -

The joint report examines the upcoming release of the Producer Price Index (PPI) on September 11 and the Consumer Price Index (CPI) on September 12, both of which are expected to play a decisive role in shaping the Federal Reserve’s interest rate decision on September 17, 2025.

- Advertisement -

Key Insights:

- Advertisement -
  • Fed in Focus: Markets are currently pricing in a 92% probability of a rate cut from 4.5% to 4.25%, according to CME FedWatch data. Softer inflation readings could further strengthen expectations of additional cuts later this year.
  • Bitcoin at a Crossroads: BTC remains below its all-time high of $124,500 reached in August. A softer CPI could propel Bitcoin past $120,000 and potentially toward $135,000 by year end, while hotter-than-expected data could trigger a correction below $107,200.
  • Equities Rally: The S&P 500 is holding above 6,500, with the potential to target 7,000 if inflation data eases and rate cut expectations firm up.
  • Cross-Asset Volatility: Inflation figures will directly impact risk assets, including cryptocurrencies, gold, silver, and growth equities, setting up traders for two critical trading windows this week.

Inflation Week: A Market-Moving Catalyst

- Advertisement -

The report underscores that falling inflation would give the Fed more flexibility to ease monetary policy, boosting liquidity across asset classes. Conversely, stronger-than-expected inflation would likely force policymakers to remain cautious, restraining rallies in both traditional and digital markets.

- Advertisement -

The full Bybit x FXStreet TradFi Report is available now on Bybit’s official platform, providing traders with in-depth analysis, technical insights, and actionable strategies to navigate one of the most important weeks for global markets this year.

- Advertisement -

#Bybit / #TheCryptoArk /#BybitResearch

- Advertisement -

About Bybit

- Advertisement -

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

- Advertisement -

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

- Advertisement -

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

- Advertisement -

Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bybit-x-fxstreet-tradfi-report-why-this-weeks-cpi-and-ppi-data-is-a-make-or-break-event-302552692.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

3 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

3 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

3 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

3 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

3 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

3 hours ago